Okyo Pharma Ltd (OKYO) Live Share Price, Invest From India

Okyo Pharma Ltd Stock Performance

as on February 7, 2026 at 7:59 am IST

Day's Low
Day's High
$1.82
Day's Price Range
$1.98
$1.94
6.19%
Downside
2.06%
Upside
52 Week's Low
52 Week's High
$1.01
52-Week Price Range
$3.35
$1.94
47.94%
Downside
72.63%
Upside

Okyo Pharma Ltd share price movements today

Previous Close: $1.90
Open: $1.82
Volume: 311.7K
Day's Low - High: $1.82 - $1.98
52 Week Low - High: $1.01 - $3.35

Okyo Pharma Ltd Historical Returns

1 Month Return: -14.67 %
3 Month Return: -21.63 %
1 Year Return: + 71.43 %
3 Year Return: -13.33 %
5 Year Return: 0 %

Okyo Pharma Ltd Stock Fundamentals & Key Indicators

Check Okyo Pharma Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$89.9M

EPS (TTM)

-0.185

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-7.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-2968.51%

Okyo Pharma Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Okyo Pharma Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Okyo Pharma Ltd	BUY	$89.9M	NA	NA	0.00%
Vertex Pharmaceuticals Incorporated	BUY	$122.3B	122.02%	33.56	31.35%
Alnylam Pharmaceuticals, Inc.	BUY	$47.7B	98.75%	1246.03	1.36%
Beone Medicines Ltd	NA	$37.4B	NA	662.33	1.38%
Regeneron Pharmaceuticals, Inc.	BUY	$80.8B	57.42%	18.28	32.13%

Stock Returns calculator for Okyo Pharma Ltd Stock including INR - Dollar returns

The Okyo Pharma Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Okyo Pharma Ltd investment value today

Current value as on today

₹1,76,523

Returns

₹76,523

(+76.52%)

Returns from Okyo Pharma Ltd Stock

₹73,214 (+73.21%)

Dollar Returns*

₹3,309 (+3.31%)

Analyst Recommendation on Okyo Pharma Ltd Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Okyo Pharma Ltd. Average target price of $10

Okyo Pharma Ltd Share Price Target

Get share price movements and forecasts by analysts on Okyo Pharma Ltd.

What analysts predicted

80.6%UPSIDE

Target Price

$10

Current Price

$1.94

Analyzed by

7 Analysts

Target

$10.00

Okyo Pharma Ltd target price $10, a slight upside of 80.6% compared to current price of $1.94. According to 7 analysts rating.

Okyo Pharma Ltd Stock’s Investor Sentiment and Interest

Search interest for Okyo Pharma Ltd Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.

Time period: January 8, 2026 to February 7, 2026

Change:183% versus previous 30 day period

Okyo Pharma Ltd Quarterly Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Okyo Pharma Ltd Annual Profit & Loss

All numbers in Millions USD

	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Total Revenue	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0
Operating Income	-4	-1	-4	-6	-13	-15	-7
EBITDA	-4	-1	-3	-6	-13	-15	-7
Interest Expense	-	0	0	-	0	1	0
Depreciation	0	0	0	0	0	0	0
Income Before Tax	-4	-1	-3	-6	-13	-16	-7
Income Tax Expense	0	0	0	0	0	0	-3
Net Income	-6	-1	-4	-7	-16	-16	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Okyo Pharma Ltd Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025
Net Income	0	0	0	0	0	0	-2	-2	-2
Operating Cash Flow	0	0	0	0	0	0	-1	-1	-1
Investing Cash Flow	-	-	-	-	-	-	0	0	-
Financing Cash Flow	0	0	0	0	0	0	2	2	4
Change in Cash	0	0	0	-	0	-	0	0	2

Okyo Pharma Ltd Annual Cash Flow

All numbers in Millions USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Income	-28	-4	-1	-3	-6	-13	-16	-7
Operating Cash Flow	-1	-1	-1	-1	-5	-7	-9	-1
Investing Cash Flow	0	0	0	0	0	0	-	0
Financing Cash Flow	0	0	0	7	2	9	6	2
Change in Cash	-1	-1	0	6	-4	1	-3	0

Global Institutional Holdings in Okyo Pharma Ltd

Funds	Holdings
Continuum Advisory, LLC	0%
Barclays PLC	0%
Citadel Advisors Llc	0%
HPM Partners LLC	0.03%
Wealth Enhancement Advisory Services, LLC	0.03%

See all

Insights on Okyo Pharma Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, OKYO has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 42.1% return, outperforming this stock by 55.4%
NEGATIVE IMPACT
Price Dip
In the last 6 months, OKYO stock has moved down by -39.2%

About Okyo Pharma Ltd

OKYO Pharma Limited is a United Kingdom-based clinical-stage biopharmaceutical company developing therapies for the treatment of dry eye disease (DED) and neuropathic corneal pain (NCP). The Company is focused on the discovery and development of novel molecules to treat neuropathic corneal pain and dry eye disease. Its research program focuses on a novel G Protein-Coupled Receptor (GPCR). The Company’s lead candidate, urcosimod, is a non-steroidal anti-inflammatory and non-opioid analgesic. Urcosimod consists of a 10-mer C-terminal Chemerin sequence, a linker (PEG-8), and Palmitic acid. It has completed a Phase II trial in patients with DED and NCP. The Company also plans to evaluate its potential in benefiting patients with ocular neuropathic pain, uveitis and allergic conjunctivitis. It is also evaluating OK-201, a bovine adrenal medulla (BAM), lipidated-peptide preclinical analogue candidate that is in the developmental stage.

Organisation	Okyo Pharma Ltd
Headquarters	14/15 Conduit St, London, United Kingdom, W1S 2XJ
CEO	Mr. Robert J. Dempsey M.B.A.
E-voting on shares	Click here to vote

Key Management of Okyo Pharma Ltd

Name	Title
Dr. Gary S. Jacob Ph.D.	Chief Development Officer & Director
Mr. Robert J. Dempsey M.B.A.	CEO & Executive Director
Mr. Michael Paul Beck	Founder
Ms. Keeren Shah	Chief Financial Officer
Dr. Rajkumar Patil Ph.D.	Chief Scientific Officer

FAQs

What is Okyo Pharma Ltd share price today?

Okyo Pharma Ltd share price today is $1.94 as on February 7, 2026 at 2:29 am IST at the close of the market. Okyo Pharma Ltd share today touched a day high of $1.98 and a low of $1.82.

What is the 52 week high and 52 week low for Okyo Pharma Ltd share?

Okyo Pharma Ltd share touched a 52 week high of $3.35 on August 8, 2025 and a 52 week low of $1.01 on February 11, 2025. Okyo Pharma Ltd stock price today i.e. February 7, 2026 at 2:29 am IST is closed at $1.94,which is 42.07% down from its 52 week high and 92.08% up from its 52 week low.

What is Okyo Pharma Ltd's market capitalisation today?

Okyo Pharma Ltd market capitalisation is $0.00T as on February 7, 2026 at 2:29 am IST.

How to invest in Okyo Pharma Ltd Stock (OKYO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Okyo Pharma Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Okyo Pharma Ltd Shares that will get you 0.7732 shares as per Okyo Pharma Ltd share price of $1.94 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Okyo Pharma Ltd Stock (OKYO) from India?

Indian investors can start investing in Okyo Pharma Ltd (OKYO) shares with as little as ₹90.555 or $1 (as of February 7, 2026 at 10:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Okyo Pharma Ltd stock (as per the Rupee-Dollar exchange rate as on February 7, 2026 at 10:39 pm IST). Based on Okyo Pharma Ltd share’s latest price of $1.94 as on February 7, 2026 at 2:29 am IST, you will get 5.1546 shares of Okyo Pharma Ltd. Learn more about fractional shares .